LEO Science & Tech Hub, the Boston-based R&D innovation unit of LEO Pharma announced that they will partner with Wearifi Inc and the Center for Bio-Integrated Electronics at Northwestern University to investigate the clinical potential of next-generation wearable electronics in dermatology research. Wearifi designs and develops the world's smallest, battery-free wearable device. The collaboration will evaluate whether the device and miniaturized sensor technology can inform and enhance drug development and treatment regimens by potentially identifying and measuring key disease-associated biomarkers. For more information see the IDTechEx report on Wearable Sensors 2018-2028.
"We are excited to be working with LEO Science & Tech Hub on developing next generation wearables that have the potential to enable personalized medicine for patients suffering from inflammatory skin disease. Natural byproducts from skin metabolism represent a powerful opportunity for biomarker discovery that may create new approaches to diagnose disease, predict clinical deteriorations, and track individual treatment responses," says Steve Xu MD, Medical Director of the Center for Bio-Integrated Electronics and Instructor in the Department of Dermatology at Northwestern University.
"Wearifi's miniature wireless devices allow for imperceptible and unobtrusive placement practically anywhere on the body and are currently used to monitor heart rate, respiration rate and UV exposure," says Anthony Banks, Chief Technology Officer for Wearifi Inc. "Partnering with a leading biopharmaceutical company like LEO to leverage this mm-scale sensor technology could potentially open new avenues to advance skin health."
"Effectively bringing Wearifi products into the dermatology space will be a challenging endeavor, but one that will push boundaries and help us better understand our limits with regards to the relationship between technology and skin health. We have an opportunity in front of us to learn informative new details about our largest organ and potentially yield pioneering results for our industry," says Troels Marstrand, Chief Data Scientist at LEO Science & Tech Hub. Initial steps will include a proof of concept study in collaboration with dermatologists and engineers at Northwestern University's Center for Bio-Integrated Electronics and Northwestern University Feinberg School of Medicine's Department of Dermatology. The teams involved will explore the feasibility of creating a wearable Volatile Organic Compound (VOC) detector for continuous measurement of both external and internal VOCs.
The LEO Science & Tech Hub is recognized for its unique collaborative approach of seeking cutting-edge technology for dermatological applications. Since its launch, the Hub has successfully formed multiple partnerships to explore minimally invasive biomarker technologies, drug delivery devices, advanced imaging systems and remote monitoring methods with leading research institutes and biotechnology companies including MIT, Epicore Biosystems, The Karp Lab, Novopyxis,Elektrofi and The Wellman Center for Photomedicine at Massachusetts General Hospital.
Source: LEO Science & Tech Hub
Top image: Wearifi Inc
Learn more at the next leading event on the topic: Wearable USA 2018 on 14 - 15 Nov 2018 at Santa Clara Convention Center, CA, USA hosted by IDTechEx.